We highly recommend you work with a doctor who is familiar with GLP-1s and GIPs, understands the intricacies of their use for weight loss, is effective at personalizing dosing, and is well-versed in helping patients integrate dietary and lifestyle interventions
Since their approval, there has been a rising interest in GLP-1 RAs, resulting in a high prescription rate for this class of medications in patients with T2DM
Many patients also ask how quickly results may appear
This helps make sure you get the right amount of thyroid hormone for your body
Common GI side effects (affecting more than 1 in 10 people) according to the SmPC: Nausea : The most frequent side effect, reported in approximately 44% of patients in clinical trials, usually most pronounced during the first few weeks and with dose increases Diarrhoea : Affects roughly 30% of users, typically mild to moderate and transient Vomiting : Occurs in about 24% of patients, often associated with eating too quickly or consuming large portions Constipation : Reported in approximately 24% of users, which may require dietary modification or occasional laxative use Abdominal pain or discomfort : Affects around 20% of patients, usually described as cramping or bloating Dyspepsia and reflux : Indigestion and heartburn occur in approximately 9% of users Less common but significant GI effects : Delayed gastric emptying : Whilst this is the intended pharmacological effect, in some cases it can cause persistent nausea, vomiting, and inability to tolerate food Pancreatitis : Has been reported in clinical trials and post-marketing
